A Study In Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00256867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16 Week Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of a New Medication (GSK523338) to Lower LDL-c and HbA1c in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.
Study identification
- NCT ID
- NCT00256867
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 369 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 18, 2005 (Actual)
- Primary completion
- Oct 31, 2006 (Actual)
- Completion
- Oct 31, 2006 (Actual)
- Last update posted
- Jul 2, 2018
2005 – 2006
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Tucson | Arizona | 85745 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Wheat Ridge | Colorado | 80033 | — |
| GSK Investigational Site | Waterbury | Connecticut | 06708 | — |
| GSK Investigational Site | Miami | Florida | 33156 | — |
| GSK Investigational Site | Saint Cloud | Florida | 34769 | — |
| GSK Investigational Site | Atlanta | Georgia | 30308 | — |
| GSK Investigational Site | Chicago | Illinois | 60607 | — |
| GSK Investigational Site | Melrose Park | Illinois | 60160 | — |
| GSK Investigational Site | Springfield | Illinois | 62704 | — |
| GSK Investigational Site | Avon | Indiana | 46123 | — |
| GSK Investigational Site | Elkhart | Indiana | 46515 | — |
| GSK Investigational Site | Sunset | Louisiana | 70584 | — |
| GSK Investigational Site | Waltham | Massachusetts | 02453 | — |
| GSK Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| GSK Investigational Site | Billings | Montana | 59102 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89103 | — |
| GSK Investigational Site | Jamaica | New York | 11432 | — |
| GSK Investigational Site | Rochester | New York | 14609 | — |
| GSK Investigational Site | Columbus | Ohio | 43212 | — |
| GSK Investigational Site | Bend | Oregon | 97701 | — |
| GSK Investigational Site | Portland | Oregon | 97216 | — |
| GSK Investigational Site | Portland | Oregon | 97219 | — |
| GSK Investigational Site | Portland | Oregon | 97239 | — |
| GSK Investigational Site | Tualatin | Oregon | 97062 | — |
| GSK Investigational Site | Beaver | Pennsylvania | 15009 | — |
| GSK Investigational Site | Fleetwood | Pennsylvania | 19522 | — |
| GSK Investigational Site | Jefferson Hills | Pennsylvania | 15025 | — |
| GSK Investigational Site | Philadelphia | Pennsylvania | 19152 | — |
| GSK Investigational Site | Clinton | South Carolina | 29325 | — |
| GSK Investigational Site | Columbia | South Carolina | 29201 | — |
| GSK Investigational Site | Kingsport | Tennessee | 37660 | — |
| GSK Investigational Site | Bryan | Texas | 77802 | — |
| GSK Investigational Site | Dallas | Texas | 75230 | — |
| GSK Investigational Site | Georgetown | Texas | 78626 | — |
| GSK Investigational Site | Midland | Texas | 79705 | — |
| GSK Investigational Site | Plano | Texas | 75093 | — |
| GSK Investigational Site | Salt Lake City | Utah | 84143 | — |
| GSK Investigational Site | Burke | Virginia | 22015 | — |
| GSK Investigational Site | Manassas | Virginia | 20110 | — |
| GSK Investigational Site | Bellevue | Washington | 98004 | — |
| GSK Investigational Site | Spokane | Washington | 99208 | — |
| GSK Investigational Site | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00256867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2018 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00256867 live on ClinicalTrials.gov.